| Particulars |
|
|
|
| Company Name
| Sun Pharmaceutical Industries Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
239.93 |
B.V. (₹) |
97.40 |
| Sales(₹ Cr.) |
20,754.64 |
NP (₹ Cr.) |
2,944.67 |
| NP Var% |
-30.00 |
Div% |
1,600.00 |
| CPS(₹) |
17.70 |
EPS (₹) |
12.30 |
| Traded Value(₹ Lakhs) |
2,133.42 |
52 Week High |
2,048.00 |
| 52 Week Low |
1,584.00 |
Price BSE |
1,905.00 |
| Price NSE |
1,905.00 |
Market Capital (₹ Cr.) |
457,073.31 |
| P/C Ratio |
107.40 |
P/E Ratio |
155.20 |
| Price Vs.BV |
19.56 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
6,056.59 |
| NP(₹ Cr.) |
871.29 |
NP Var % |
54.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
19,974.06 |
| OPM |
27.90 |
NP |
2,757.03 |
| NP Var% |
-25.56 |
EPS |
14.55 |
| PE |
130.93 |
|
|